SAN ANTONIO (MedPage Today) -- Is treatment that lasts twice as long any better than some of the standard therapies in breast cancer? That's the question underlying two major trials that will headline the San Antonio Breast Cancer Symposium this week. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment